HYPOTHESIS AND THEORY article
Front. Pediatr., 16 February 2022
Sec. Genetics of Common and Rare Diseases
Volume 9 - 2021 | https://doi.org/10.3389/fped.2021.708555
RETRACTED: ORMDL3 Promotes Angiogenesis in Chronic Asthma Through the ERK1/2/VEGF/MMP-9 Pathway
Zhen Ding 1†
Fei Yu 1†
Yan Sun 2*
Ning Jiao 1‡
Lina Shi 1‡
Jinghong Wan 1
Qinghua Liu 1
1. Department of Pediatrics, Zibo Hospital of Traditional Chinese Medicine, Zibo, China
2. Department of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
Summary
Citation
Ding Z, Yu F, Sun Y, Jiao N, Shi L, Wan J and Liu Q (2022) RETRACTED: ORMDL3 Promotes Angiogenesis in Chronic Asthma Through the ERK1/2/VEGF/MMP-9 Pathway. Front. Pediatr. 9:708555. doi: 10.3389/fped.2021.708555
Received
12 May 2021
Accepted
09 December 2021
Published
16 February 2022
Volume
9 - 2021
Edited by
Stefania Martucciello, University of Salerno, Italy
Reviewed by
Shaoxi Cai, Southern Medical University, China; Sinem Firtina, University of Istinye, Turkey
Updates
†These authors have contributed equally to this work and share first authorship
‡These authors have contributed equally to this work
This article was submitted to Genetics of Common and Rare Diseases, a section of the journal Frontiers in Pediatrics
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.